ATP6V0D2 and kidney cancer: Previous studies also supported our result that ATP6V0D1 was widely expressed, while D2 was mainly expressed on the cell surface of human kidneys and osteoclasts [29]; ATP6V0D2 is also overexpressed in most cancer tissues such as in melanoma, pancreatic cancer, and kidney cancer [30].